Key result
The concurrent presence of cancer and cardiac disease increasingly requires comanagement due to improved cancer survival and treatment-induced cardiotoxicities.
Highlights the growing importance of cardio-oncology and the comanagement of cancer and heart disease in oncology nursing.
February, which is American Heart Month, is the optimal time to consider the unique role of heart health in the context of cancer care. As the two leading causes of death in the United States (National Center for Health Statistics, 2020), cancer and cardiac disease share an ominous connection that is further exacerbated when they occur concurrently. Increased overall survival for patients with cancer coupled with chronic cardiac conditions or treatment-induced cardiotoxicities increasingly requires comanagement of cancer and heart disease (Gilchrist et al., 2019).
No takes yet. Share an insight, caveat, or question.
Anecita Fadol (2021) conducted an editorial in Cancer and cardiac disease. The concurrent presence of cancer and cardiac disease increasingly requires comanagement due to improved cancer survival and treatment-induced cardiotoxicities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: